4893 items matching your search terms.

Level of agreement between prehospital and emergency department vital signs in trauma patients

Dinh, M.M. Oliver, M. Bein, K.J. Muecke, S. Carroll, T. Veillard, A.S. Gabbe, B.J. Ivers, R.
EMERGENCY MEDICINE AUSTRALASIA, 2013     DOI:10.1111/1742-6723.12126

Towards generic online multicriteria decision support in patient-centred health care

Dowie, J. Kjer Kaltoft, M. Salkeld, G. Cunich, M.
HEALTH EXPECTATIONS, 2013     DOI:10.1111/hex.12111

Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study

Du, M. Basu, A. Fu, D. Wu, M. Centola, M. Jenkins, A. J. Hanssen, K. F. Garg, S. K. Hammad, S. M. Scardo, J. A. Aston, C. E. Lyons, T. J.
DIABETES CARE, 2013     DOI:10.2337/dc12-1934

National cervical screening program renewal: evidence review

Dyer, S. Lewis, S. Lord, S. Stoklosa, A Wortley, S. Cervical Screening Steering Committee, and the Medical Services Advisory Committee,

Identification of the sentinel lymph node in the SNAC-1 trial

Elmadahm, A Gill, P Bochner, M. A. Gebski, V Zannino, D Stockler, M Uren, R
, 2013     DOI:10.1016/j.breast.2014.05.015

Factors predicting the nodal involvement in early breast cancer

Elmadahm, A Gill, P Farshid, G Gebski, V Bilous, M Lord, S Lee, C Wetzig, N
, 2013     DOI:10.1016/j.breast.2014.05.016

Circulating non-coding RNAs as biomarkers of beta cell death in diabetes

Farr, R.J. Joglekar, M.V. Taylor, C.J. Hardikar, A.A.

Small cell lung cancer update

Ferraro, D. Millward, C.

A randomised phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET)

Field, KM Simes, J Wheeler, H Hovey, EJ Nowak, AK Cher, L Brown, C Livingstone, A Sawkins, K Rosenthal, M CABARET/COGNO Investigators,

Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Fox, P Gao, B Balakrishnar, B Menzies, AM Yeap, SH Ali, SA Gebski, V Provan, P Coulter, S Liddle, C Hui, R Kefford, R Lynch, J Wilcken, N Balleine, R Gurney, H

Markers of systemic inflammation predict survival in patients with advanced renal cell cancer

Fox, P. Hudson, M. Brown, C. Lord, S. Gebski, V. De Souza, P. Lee, C.K.
BRITISH JOURNAL OF CANCER, 2013     DOI:10.1038/bjc.2013.300

Factors delaying chemotherapy for breast cancer in four urban and rural oncology units

Fox, P. N. Chatfield, M. D. Beith, J. M. Allison, S. Della-Fiorentina, S. Fisher, D. Turley, K. Grimison, P. S.
ANZ JOURNAL OF SURGERY, 2013     DOI:10.1111/j.1445-2197.2012.06254.x

PARAGON: Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynecologic neoplasms: ANZGOG 0903

Friedlander, M Sjoquist, KM Sommeijer, DW Bailey, L Martyn, J Gillies, K Mileshkin, LR O'Connell, R Gebski, V Vaughan, MM Blomfield, P Beale, PJ Quinn, M Stockler, MR Lombard, JM Hadley, AM Amant, F Edmondson, RJ

Patient-reported outcomes in ovarian cancer clinical trials

Friedlander, M.L. King, M.T.
ANNALS OF ONCOLOGY, 2013     DOI:10.1093/annonc/mdt47

Clinical trials of palliative chemotherapy in platinum-resistant or -refractory ovarian cancer: time to think differently? [letter]

Friedlander, M.L. Stockler, M.R. Butow, P. King, M.T. McAlpine, J. Tinker, A. Ledermann, J.A.
JOURNAL OF CLINICAL ONCOLOGY, 2013     DOI:10.1200/JCO.2012.47.7927